KeystoneBio
Benefits
Specifications
How-to
Contact Us
Learn More
Automating Biotech
Market Analysis
Benefits
Put your discoveries on the path to value creation, without data overload
What patients need and the industry wants.
Understand the path to validation
Understand which data readouts have proven value for similar programs. Discern publicly available validating data points at the time of a BD deal. Track patterns in pharma dealmaking over time.
Estimate short and long term program value
Understand deals in your category including specific terms. Discern publicly available validating data points. Estimate peak revenue potential by identifying where you fit in the patient journey and potential share. Understand deal outcomes at each stage of development.
Analyze the right source data
Ensure you have deep understanding of the right market-driving data points in your category, across public, paywalled, and proprietary sources.
Prompt data directly
Generate precise, visually compelling reports that illustrate where you fit in the landscape and how you are differentiated.
A sample of our data sources
Benefits
Always adding
disease areas
Our algorithms perform at 95-100% accuracy based on human expert benchmarks. We don’t release new disease area capabilities until we’re certain of accuracy
Current Focus
Metabolic
Disorders affecting the body’s ability to convert food into energy, such as diabetes and obesity, which are rising globally and linked to multiple chronic conditions.
Next Up
Neurology
Conditions of the brain and nervous system, including Alzheimer’s, Parkinson’s, and epilepsy, where patient need is high and therapeutic innovation remains a major unmet opportunity.
Coming Soon
Inflammation & Immunology
Diseases driven by immune system dysregulation—like rheumatoid arthritis, lupus, and IBD—offering strong pipelines for innovation amid increasing autoimmune prevalence.
Coming Soon
Oncology
Encompasses the study and treatment of cancers, an evolving field with high clinical demand and significant attention due to its potential for breakthrough therapies.
About
We’re building AI market research agents that can automate complex value assessments, identify deal opportunities, pinpoint the right data benchmarks, and highlight key tradeoffs.
Connect with us
Be first in line when KeystoneBio launches, and receive updates as we build the better way to aim your drug development.
Request access
© KeystoneBio
2025
All Rights Reserved
KeystoneBio
Join the waitlist
Benefits
Specifications
How-to
Contact Us
Learn More
Automating Biotech
Market Analysis
Benefits
Put your discoveries on
the path to business value, without data overload
What patients need and the industry wants.
Understand the path to validation
Understand which data readouts have proven value for similar programs. Discern publicly available validating data points at the time of a BD deal. Track patterns in pharma dealmaking over time.
Estimate short and long term program value
Understand deals in your category including specific terms. Discern publicly available validating data points. Estimate peak revenue potential by identifying where you fit in the patient journey and potential share. Understand deal outcomes at each stage of development.
Analyze the right source data
Ensure you have deep understanding of the right market-driving data points in your category, across public, paywalled, and proprietary sources.
Prompt data directly
Generate precise, visually compelling reports that illustrate where you fit in the landscape and how you are differentiated.
A sample of our data sources
Benefits
Always adding disease areas
Our algorithms perform at 95-100% accuracy based on human expert benchmarks. We don’t release new disease area capabilities until we’re certain of accuracy
Current Focus
Metabolic
Disorders affecting the body’s ability to convert food into energy, such as diabetes and obesity, which are rising globally and linked to multiple chronic conditions.
Next Up
Neurology
Conditions of the brain and nervous system, including Alzheimer’s, Parkinson’s, and epilepsy, where patient need is high and therapeutic innovation remains a major unmet opportunity.
Coming Soon
Inflammation & Immunology
Diseases driven by immune system dysregulation—like rheumatoid arthritis, lupus, and IBD—offering strong pipelines for innovation amid increasing autoimmune prevalence.
Coming Soon
Oncology
Encompasses the study and treatment of cancers, an evolving field with high clinical demand and significant attention due to its potential for breakthrough therapies.
About
We’re building AI market research agents that can automate complex value assessments, identify deal opportunities, pinpoint the right data benchmarks, and highlight key tradeoffs.
Connect with us
Be first in line when KeystoneBio launches, and receive updates as we build the better way to aim your drug development.
Request access
© KeystoneBio
2025
All Rights Reserved
For biotechs
For investors
For pharma
Contact us
Automating Biotech
Market Analysis
Benefits
Put your discoveries on
the path to business value, without data overload
What patients need and the industry wants.
Understand the path to validation
Understand which data readouts have proven value for similar programs. Discern publicly available validating data points at the time of a BD deal. Track patterns in pharma dealmaking over time.
Estimate short and long term program value
Estimate peak revenue potential with a guided market share analysis. Understand deal outcomes at each stage of development.
Analyze the right source data
Ensure you have deep understanding of the right market-driving data points in your category, across public, paywalled, and proprietary sources.
Prompt data directly
Generate precise, visually compelling reports that illustrate where you fit in the landscape and how you are differentiated.
A sample of our data sources
Benefits
Always adding disease areas
Our algorithms perform at 95-100% accuracy based on human expert benchmarks. We don’t release new disease area capabilities until we’re certain of accuracy
Current Focus
Metabolic
Disorders affecting the body’s ability to convert food into energy, such as diabetes and obesity, which are rising globally and linked to multiple chronic conditions.
Next Up
Neurology
Conditions of the brain and nervous system, including Alzheimer’s, Parkinson’s, and epilepsy, where patient need is high and therapeutic innovation remains a major unmet opportunity.
Coming Soon
Inflammation & Immunology
Diseases driven by immune system dysregulation—like rheumatoid arthritis, lupus, and IBD—offering strong pipelines for innovation amid increasing autoimmune prevalence.
Coming Soon
Oncology
Encompasses the study and treatment of cancers, an evolving field with high clinical demand and significant attention due to its potential for breakthrough therapies.
About
We’re building AI market research agents that can automate complex value assessments, identify deal opportunities, pinpoint the right data benchmarks, and highlight key tradeoffs.
Connect with us
Be first in line when KeystoneBio launches, and receive updates as we build the better way to aim your drug development.
Request access
© KeystoneBio
2025
All Rights Reserved